U.S. Markets closed

Athenex Inc (ATNX) CEO and Chairman of the Board Johnson Yiu Nam Lau Bought $74,900 of Shares

CEO and Chairman of the Board of Athenex Inc (30-Year Financial, Insider Trades) Johnson Yiu Nam Lau (insider trades) bought 5,000 shares of ATNX on 08/23/2019 at an average price of $14.98 a share. The total cost of this purchase was $74,900.

Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Athenex Inc has a market cap of $1.15 billion; its shares were traded at around $14.83 with and P/S ratio of 12.17. GuruFocus has detected 3 severe warning signs with Athenex Inc. .

CEO Recent Trades:

  • CEO and Chairman of the Board, 10% Owner Johnson Yiu Nam Lau bought 5,000 shares of ATNX stock on 08/23/2019 at the average price of $14.98. The price of the stock has decreased by 1% since.
  • CEO and Chairman of the Board, 10% Owner Johnson Yiu Nam Lau bought 10,000 shares of ATNX stock on 08/15/2019 at the average price of $14.9. The price of the stock has decreased by 0.47% since.

Directors and Officers Recent Trades:

  • 10% Owner Life Sciences Maste Perceptive bought 50,000 shares of ATNX stock on 08/16/2019 at the average price of $14.98. The price of the stock has decreased by 1% since.
  • EVP, Chief Medical Officer Rudolf Kwan bought 1,000 shares of ATNX stock on 08/15/2019 at the average price of $14.85. The price of the stock has decreased by 0.13% since.
  • 10% Owner Life Sciences Maste Perceptive bought 808,481 shares of ATNX stock on 08/08/2019 at the average price of $14.67. The price of the stock has increased by 1.09% since.

For the complete insider trading history of ATNX, click here

.This article first appeared on GuruFocus.